Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Serrano

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
JNCI Cancer Spectrum|January 7, 2021
Low-Dose Aspirin in High-Risk Individuals With Screen-Detected Subsolid Lung Nodules: A Randomized Phase II TrialBernardo Bonanni, Davide Serrano, Patrick Maisonneuve, et al.
NPJ Breast Cancer|March 26, 2021
Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trialAndrea DeCensi, Harriet Johansson, Thomas Helland, et al.
Breast Cancer Research and Treatment|September 26, 2014
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trialAndrea DeCensi, Matteo Puntoni, Sara Gandini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2007
Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy usersAndrea Decensi, Sara Gandini, Davide Serrano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Dual effect of metformin on breast cancer proliferation in a randomized presurgical trialBernardo Bonanni, Matteo Puntoni, Massimiliano Cazzaniga, et al.
Plos One|September 3, 2024
Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancerAliana Guerrieri-Gonzaga, Davide Serrano, Patrizia Gnagnarella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2021
Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive DiseaseAndrea DeCensi, Matteo Puntoni, Harriet Johansson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2019
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial NeoplasiaAndrea DeCensi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.
Neoplasia (New York, N.Y.)|October 24, 2022
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patientsFederica Bellerba, Davide Serrano, Johansson Harriet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2025
Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 TrialHarriet Johansson, Debora Macis, Martino Oliva, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
JNCI Cancer Spectrum|January 7, 2021
Low-Dose Aspirin in High-Risk Individuals With Screen-Detected Subsolid Lung Nodules: A Randomized Phase II TrialBernardo Bonanni, Davide Serrano, Patrick Maisonneuve, et al.
NPJ Breast Cancer|March 26, 2021
Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trialAndrea DeCensi, Harriet Johansson, Thomas Helland, et al.
Breast Cancer Research and Treatment|September 26, 2014
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trialAndrea DeCensi, Matteo Puntoni, Sara Gandini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2007
Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy usersAndrea Decensi, Sara Gandini, Davide Serrano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Dual effect of metformin on breast cancer proliferation in a randomized presurgical trialBernardo Bonanni, Matteo Puntoni, Massimiliano Cazzaniga, et al.
Plos One|September 3, 2024
Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancerAliana Guerrieri-Gonzaga, Davide Serrano, Patrizia Gnagnarella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2021
Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive DiseaseAndrea DeCensi, Matteo Puntoni, Harriet Johansson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2019
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial NeoplasiaAndrea DeCensi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.
Neoplasia (New York, N.Y.)|October 24, 2022
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patientsFederica Bellerba, Davide Serrano, Johansson Harriet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2025
Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 TrialHarriet Johansson, Debora Macis, Martino Oliva, et al.
Pageof 9